QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NASDAQ:PTRA

Proterra (PTRA) Stock Forecast, Price & News

$1.19
-0.05 (-4.03%)
(As of 04:00 PM ET)
Compare
Today's Range
$1.17
$1.28
50-Day Range
$1.00
$1.52
52-Week Range
$0.91
$7.71
Volume
1.45 million shs
Average Volume
2.29 million shs
Market Capitalization
$270.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.76

Proterra MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
300.0% Upside
$4.76 Price Target
Short Interest
Healthy
7.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$52,046 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.87) to ($0.34) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.00 out of 5 stars

Auto/Tires/Trucks Sector

38th out of 98 stocks

Motor Vehicles & Car Bodies Industry

9th out of 32 stocks


PTRA stock logo

About Proterra (NASDAQ:PTRA) Stock

Proterra Inc. provides commercial vehicles in the United States, the European Union, Canada, the United Kingdom, Australia, Japan, and Türkiye. The company's Proterra Powered & Energy business unit offers battery systems and electrification solutions for commercial vehicle original equipment manufacturer (OEM) customers serving delivery trucks, school buses, coach buses, construction and mining equipment, and other applications; and turnkey fleet-scale, high-power charging solutions and software services, ranging from fleet and energy management software-as-a-service to fleet planning, hardware, infrastructure, installation, utility engagement, and charging optimization. Its Proterra Transit business unit designs, develops, manufactures, and sells electric transit buses as an OEM for North American public transit agencies, airports, universities, and other commercial transit fleets. The company was founded in 2004 and is headquartered in Burlingame, California.

Receive PTRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proterra and its competitors with MarketBeat's FREE daily newsletter.

PTRA Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Proterra: 3 Reasons I Am Staying Away
Proterra (NASDAQ: PTRA)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
8-K: Proterra Inc
Proterra (PTRA) Gets a Sell from Bank of America Securities
Brokerages Set Proterra Inc. (NASDAQ:PTRA) PT at $5.69
Proterra (NASDAQ:PTRA) Price Target Cut to $1.80
Proterra (NASDAQ:PTRA) PT Lowered to $5.00 at DA Davidson
See More Headlines

PTRA Price History

PTRA Company Calendar

Last Earnings
5/09/2023
Today
6/09/2023
Next Earnings (Estimated)
8/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Motor vehicles & car bodies
Sub-Industry
N/A
Current Symbol
NASDAQ:PTRA
Fax
N/A
Employees
1,247
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.76
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$1.80
Forecasted Upside/Downside
+303.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-237,950,000.00
Net Margins
-130.74%
Pretax Margin
-130.74%

Debt

Sales & Book Value

Annual Sales
$309.36 million
Book Value
$2.28 per share

Miscellaneous

Free Float
218,278,000
Market Cap
$267.74 million
Optionable
Not Optionable
Beta
0.89

Key Executives

  • Mr. Gareth T. JoyceMr. Gareth T. Joyce (Age 50)
    Pres, CEO & Director
    Comp: $862.22k
  • Mr. Julian R. Soell
    Chief Operating Officer
  • Mr. Christopher L. Bailey (Age 42)
    Chief Bus. Officer
    Comp: $603.25k
  • Mr. David S. Black (Age 61)
    Chief Financial Officer
  • Mr. Dustin Grace (Age 41)
    Chief Technology Officer
  • Mr. Dustin Goodwin
    Chief Information Officer
  • Mr. Aaron Chew
    VP of Investor Relations
  • Jeffrey E. Mitchell
    Interim Gen. Counsel & Corp. Sec.
  • Sara Dadyar
    Chief People Officer
  • Mr. Richard W. Huibregtse (Age 60)
    Sr. VP of Engineering













PTRA Stock - Frequently Asked Questions

Should I buy or sell Proterra stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Proterra in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PTRA shares.
View PTRA analyst ratings
or view top-rated stocks.

What is Proterra's stock price forecast for 2023?

3 analysts have issued 12 month target prices for Proterra's shares. Their PTRA share price forecasts range from $1.80 to $7.00. On average, they predict the company's stock price to reach $4.76 in the next twelve months. This suggests a possible upside of 303.4% from the stock's current price.
View analysts price targets for PTRA
or view top-rated stocks among Wall Street analysts.

How have PTRA shares performed in 2023?

Proterra's stock was trading at $3.77 at the start of the year. Since then, PTRA stock has decreased by 68.7% and is now trading at $1.18.
View the best growth stocks for 2023 here
.

When is Proterra's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our PTRA earnings forecast
.

How were Proterra's earnings last quarter?

Proterra Inc. (NASDAQ:PTRA) announced its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.03. The company had revenue of $79.53 million for the quarter. Proterra had a negative trailing twelve-month return on equity of 52.23% and a negative net margin of 130.74%.

What guidance has Proterra issued on next quarter's earnings?

Proterra issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $450.00 million-$500.00 million, compared to the consensus revenue estimate of $468.52 million.

What is Proterra's stock symbol?

Proterra trades on the NASDAQ under the ticker symbol "PTRA."

Who are Proterra's major shareholders?

Proterra's stock is owned by many different institutional and retail investors. Top institutional investors include Franklin Resources Inc. (13.12%), BlackRock Inc. (6.75%), State Street Corp (2.27%), Geode Capital Management LLC (1.83%), First Trust Advisors LP (0.65%) and CWM LLC (0.49%). Insiders that own company stock include Christopher L Bailey, Gareth T Joyce, Joann Covington, Julian R Soell and Karina F Padilla.
View institutional ownership trends
.

How do I buy shares of Proterra?

Shares of PTRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Proterra's stock price today?

One share of PTRA stock can currently be purchased for approximately $1.18.

How much money does Proterra make?

Proterra (NASDAQ:PTRA) has a market capitalization of $267.74 million and generates $309.36 million in revenue each year. The company earns $-237,950,000.00 in net income (profit) each year or ($2.41) on an earnings per share basis.

How many employees does Proterra have?

The company employs 1,247 workers across the globe.

How can I contact Proterra?

Proterra's mailing address is 200 CLARENDON STREET 55TH FLOOR, BOSTON MA, 02116. The official website for the company is www.proterra.com. The company can be reached via phone at 864-438-0000 or via email at ir@proterra.com.

This page (NASDAQ:PTRA) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -